Responsiveness and Acceptability for Human Papilloma Virus (HPV) Vaccine Among Parents of Adolescent Girls in Port Harcourt City, Rivers State
Article Sidebar
Page Numbers:
25-48
Digital Object Identifier:
10.58578/ajmsphr.v2i1.4536
Viewed: 274 times
Downloaded: 307 times
LYAS Publisher cordially invites qualified professionals to serve as Editors or Reviewers. Your expertise will make an important contribution to maintaining and strengthening the academic quality of our publications. Interested applicants are kindly requested to complete the application form at the following link: Editors & Reviewers
Please feel free to contact us if you need any further information about the submission process or if you have any additional questions.
Authors:
Bright-Okere Ugochi N1, Imarenezor Edobor Peter Kenneth2 
Copyright :
Authors retain copyright and grant the journal right of first publication.
Main Article Content
Abstract
Human Papilloma Virus (HPV) infections and cervical cancer in Nigeria is of high prevalence. Despite this, the acceptance and utilization of the HPV vaccine which has a high effective preventive measure remain low. The aim of the study was to examine the responsiveness and acceptability of the human papilloma virus (HPV) vaccine among parents of adolescent girls in Rivers State, particularly Port Harcourt City. A descriptive cross-sectional study was adopted for this study. A multi-stage sampling method was used for recruiting a total of three hundred and fifty-seven (357) parents with one hundred and eighty (180) males and one hundred and seventy-seven (177) females used in the study across different age groups (21–60) years for the investigation. The results data obtained using an interviewer based semi-structured questionnaire and the Statistical Package for the Social Sciences (SPSS) version 29 was used in the data analysis. The findings disclosed varying degrees of awareness and understanding of HPV, cervical cancer, and the HPV vaccine, with healthcare providers being the primary source of information 120 (33.6%). Cultural beliefs and religious factors significantly affect vaccine acceptance by 180 (50.4%) and 120 (36.4%) respectively. In terms of Responses on attitude and perceptions regarding safety and efficacy of HPV vaccine, 210 (58.8%) are aware and ready to accept the vaccine, 70 (19.6%) are not ready to take the vaccine while 77 (21.6%) are not sure if they are ready to accept the vaccine. Barriers like cost and accessibility also influence willingness to vaccinate, as findings showed majority of the participants feel the high cost, location and availability of the vaccines is an issue. Statistically, a positive and statistically significant correlation (r = 0.230, p < 0.01) was found between cultural beliefs in the community and the likelihood of vaccinating daughters if religious leaders encourage it. On the other hand, the correlation between cultural beliefs and perceived affordability of the HPV vaccine were negative (r = -0.115, p < 0.05), indicating that parents who consider cultural beliefs in their decision-making may also perceive the vaccine as less affordable, potentially limiting access for financially constrained families. Similarly, there is a positive correlation between the likelihood of vaccinating if religious leaders encourage it and the perceived affordability of the vaccine (r = 0.187, p < 0.01). This suggests that religious influence may reduce the perceived financial barrier, perhaps by increasing the perceived importance of vaccination among parents. Interestingly, the perceived affordability of the vaccine is also negatively correlated with refraining from healthcare services This study in all, revealed important influences between socio-cultural, economic, and service delivery elements in shaping vaccine uptake and emphasizes the need for enhanced education, reduced logistical obstacles, and a focus on addressing cultural concerns to improve both acceptability and accessibility of the HPV vaccine in the study area. Also, the result provides essential baseline data on HPV prevalence among individuals in Port Harcourt City, highlighting the need for continued surveillance and targeted interventions in this area to reduce the risk of HPV transmission.
Article Details
References
Archibong, B., & Annan, F. (2021, December 3). What do Pfizer’s 1996 drug trials in Nigeria teach us about vaccine hesitancy? Retrieved from Bookings : https://www.brookings.edu/articles/what-do-pfizers-1996-drug-trials-in-nigeria-teach-us-about-vaccine-hesitancy/
Asempah, E. (2021). Cervical Cancer Prevalence in sub-Saharan Africa and HPV Vaccination Policy: A Public Health Grand Challenge? Journal of Cancer Immunology, Volume 3, Issue 2, 87-97.
Balogun, F. M., & Omotade, O. O. (2022). Parental intention to vaccinate adolescents with HPV vaccine in selected communities in Ibadan, Southwest Nigeria: an application of Integrated Behavioral Model. Human Vaccines & Immunotherapeutic 2022, Vol. 18, NO. 5, e2069959 https://doi.org/10.1080/21645515.2022.2069959, 1-10.
Ben-Enukora, C., Oyero, O., Okorie, N., Odiboh, O. O., & Adeyeye, B. K. (2020). Analysis of 2017 risk communication on Human Monkey Pox outbreak in Nigeria’s News Media. International Journal of Education and Information Technologies, Volume 14, 2020, DOI: 10.46300/9109.2020.14.9, 69-75.
Enebe, J. T., Enebe, N. O., Agunwa, C. C., Nduagubam, O. C., Okafor, I. I., Aniwada, E. C., & Aguwa, E. N. (2021). Awareness, acceptability and uptake of cervical cancer vaccination services among female secondary school teachers in Enugu, Nigeria: a cross-sectional study. Pan African Medical Journal (ISSN: 1937-8688), 1-16.
Ezeanochie, M., & Olasimbo, P. (2020). Awareness and uptake of human papilloma virus vaccines among female secondary school students in Benin City, Nigeria. African H 45 ealth Sciences Vol 20 Issue 1, March,, 45-50.
Imarenezor Edobor Peter Kenneth, Anyiam Ifeoma Vivian, Abhadionmhen Abel Onolunosen, Ndubuisi Miracle Nneoma & Ekeh Amarachi Promise (2023). Human Immunodeficiency Virus (HIV), Hepatitis B Virus (HBV), and Hepatitis C Virus (HCV) Co-Infections among Patients attending General Hospital, Wukari, Taraba State, North East, Nigeria. International Journal of Medical and All Body Health Research, 4 (2): 36-42.
Imarenezor Edobor Peter Kenneth, Anyiam Vivian Ifeoma, Ofiri Pascal Ngozi & Abhadionmhen Onolunosen Abel (2024). Pervasiveness of Human Immuno-Deficiency Virus (HIV), among Individuals in Wukari, Taraba State, North-East Nigeria. Int. J. Adv. Biol. Biomed. Res., 12(3), 237-247.
Jibril, A. M., Hassan, Z. A., & Abdulwahab, R. I. (2021). Socioeconomic determinants of HPV vaccine uptake in Northern Nigeria: A cross-sectional study. Vaccine, 39(15). https://doi.org/10.1016/j.vaccine.2021.02.031, 2153-2160.
John-Akinola, Y. O., Ndikom, C. M., Oluwasanu, M. M., & Adebisi, T. (2022). Cervical Cancer and Human Papillomavirus Vaccine Knowledge, Utilisation, Prevention Educational Interventions and Policy Response in Nigeria: A Scoping Review. Cancer Control, Volume 29: 1–11. DOI: 10.1177/10732748221130180.
Mohammed, A. O., Oladipo, O., & Bello, F. O. (2019). Perception of HPV risk and vaccine acceptability among Nigerian parents: A multi-state survey. African Journal of Reproductive Health, 23(2). https://doi.org/10.29063/ajrh2019/v23i2.12, 110-119.
Nguyen, L. T., Phan , D. Q., Gyan, A., Nguyen , H. T., Cassell, D., & Huynh , G. (2024). Parents’ Intentions of Human Papillomavirus Vaccination for Students in Vietnam: A Cross- Sectional Study. Cancer Control Volume 31: 1–8, DOI: 10.1177/10732748241284907 journals.sagepub.com/home/ccx .
Ofiri Pascal Ngozi, Imarenezor Edobor Peter Kenneth, Anyiam Vivian Ifeoma & Abhadionmhen Onolunosen Abel (2024). HIV/AIDS Prevalence in Taraba State, North East, Nigeria; Case Study: Wukari and Environs. Int. j. adv. multidisc. res. stud. 2024; 4(5):6-10. DOI: https://doi.org/10.62225/2583049X.2024.4.5.3182
Rabiu, I., & Yahuza, Z. (2023). Knowledge and Attitude towards Human Papilloma Virus Infection, Vaccines, and Cervical Cancer Prevention among School Students in Kano, Nigeria. Advances in Virology Volume 2023, Article ID 2803420, https://doi.org/10.1155/2023/2803420, 1-10.
WHO (2023). HPV vaccine and the prevention of cervical cancer: Global progress and challenges.
WHO HPV Report. Retrieved from https://www.who.int/initiatives/hpv-vaccine.